Group items tagged

Genetic Testing of 18 Hereditary Cancer This test can provide risk assessment in high-risk groups with a family history by detecting gene mutations in the entire coding region and splice region of 64 genes associated with 18 hereditary tumors at one time.

Hereditary Deafness Gene Detection (227 Genes+Mitochondrial Genome) This test is based on NGS technology, it can detect 227 nuclear genomes + mitochondrial genome sequence, covering reported non-syndromic deafness and syndrome deafness.

According to research reports, individuals with inherited cancer genes have a higher risk of cancer than ordinary people. About 7% of breast cancer and 1%-15% of ovarian cancer are caused by BRCA1/BRCA2 gene mutations. In families with a high incidence of breast and ovarian cancer, 80% of patients have mutations in the BRCA1/BRCA2 gene, and this gene is inherited in an autosomal dominant manner in the population. This test detects the entire coding region of BRCA1/BRCA2 genes, and 20bp intron regions upstream and downstream of the coding region, in addition to known mutation hotspot genes, unknown mutations can be detected.

Individualized Medication Guidance for Breast Cancer This test detects 348 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for breast cancer patients.